细胞培养容器市场 - 全球产业规模、份额、趋势、机会、预测：按类型、产品、最终用途、地区和竞争格局划分，2021-2031年

全球细胞培养容器市场预计将从 2025 年的 49.5 亿美元成长到 2031 年的 81.3 亿美元，复合年增长率为 8.62%。

这些容器包括多孔孔盘、滚瓶、培养皿和烧瓶等专用无菌容器，旨在支持细胞在受控的体外环境中维持和增殖。市场成长趋势主要受生物製药产业的快速发展所驱动，特别是对单株抗体、疫苗和细胞疗法等治疗慢性疾病所需药物的需求不断增长。此外，药物研发活动的活性化和严格的毒性测试要求也确保了对这些重要实验室耗材的稳定需求。

对科学技术创新的大量投资进一步推动了该领域的发展，并直接促进了培养容器的使用。根据欧洲製药工业协会联合会 (EFPIA) 的报告，预计到 2024 年，欧洲以研发为基础的製药业在研发方面的支出将达到约 550 亿欧元。然而，儘管存在这些有利趋势，市场在污染控制方面仍面临重大挑战。培养过程中持续存在的交叉污染威胁对生产者和研究人员来说都是一项重大挑战，会导致代价高昂的批次失败风险，并降低实验数据的可靠性。

市场驱动因素

全球对疫苗和生物製药的需求激增是细胞培养容器市场的主要驱动力。随着製药公司专注于生产单株抗体和病毒载体，对可靠的无菌隔离系统（例如滚瓶和多孔孔盘）的需求不断增长，从而促进了大规模的上游工程加工。这一生产趋势在基础设施的大规模资本投资中得到了明确的体现。例如，诺华公司在2025年4月的企业新闻稿中宣布，计划在未来五年内投资230亿美元，用于扩大其在美国的生产和研发设施。这种扩张也为耗材供应商带来了经济效益。康宁公司在2025年1月的财报中指出，其生命科学部门的年销售额成长了8%，达到20亿美元，这主要得益于生物製程需求的持续成长。

干细胞和再生医学行业的快速扩张，由于对专业培养环境的需求，进一步加速了市场成长。与传统生物製药不同，细胞和基因疗法通常需要复杂的容器形状，以确保自体或异体移植细胞培养过程中最佳的气体交换和细胞黏附。该领域持续吸引大量资金，从而确保了高性能培养设备的稳定供应链。根据再生医学联盟在2024年10月举行的「细胞与基因会议」（Cell & Gene Meeting on the Mesa）上发布的资料，仅2024年上半年，全球对该领域的投资就达到了109亿美元，为临床研发提供了资金支持。这直接转化为对必需的一次性培养袋和培养瓶的需求成长。

市场挑战

污染控制仍然是全球细胞培养容器市场的一大障碍，严重限制了企业的财务表现和营运效率。生物製药生产过程中固有的交叉污染风险迫使製造商实施极为严格的检验和灭菌措施。这些必要但繁琐的程序导致营运成本增加、生产前置作业时间延长，最终降低整体产量。此外，实际发生的污染事件可能导致灾难性的批次失败，需要丢弃高价值的生物製品，并严重延误关键治疗方法的上市进程。

从数据中可以看出，业界对降低这些风险的重视程度显而易见。根据PDA 2024年的一项调查，超过80%的受访製造商加强了验证程序，以满足日益严格的污染控制标准。这种将大量资源投入无菌保证和合规性的倡议，使得原本用于创新和产能扩张的资金减少。因此，持续存在的污染威胁不仅损害了产品的完整性，也为扩充性和市场准入设置了高壁垒，直接阻碍了产业的成长。

市场趋势

随着生物製药企业将操作一致性和高通量筛检置于优先地位，自动化容器的设计研发正在加速。为了实现与机器人移板机和液体处理系统的无缝集成，容器设计正朝着标准化的微孔盘形状发展。这造就了坚固耐用、与机械手相容的结构，从而消除了人工操作带来的许多不确定性。这种向标准化、自动化耗材的产业趋势也反映在主要供应商的财务表现上。例如，赛多利斯斯泰迪生技公司（Sartorius Stedim Biotech）在2025年1月发布的2024财年中期财务报告中指出，其销售额达27.8亿欧元，耗材业务也显着復苏，这得益于客户调整库存水准以支援自动化生物製程活动。

同时，用于三维细胞培养的专用容器的出现，透过提供比传统单层培养更接近生理环境的培养条件，正在改变药物研发的工作流程。研究人员越来越多地采用先进的支架、微流体晶片和超低黏附培养板，这些设备旨在促进类器官和球状体的生长，从而在疗效和毒性测试中提供更优的预测数据。对这些先进培养平台的需求显着推动了主要企业持续的收入成长。正如赛默飞世尔科技公司在2025年1月发布的《2024财年第四季及全年报告》中所述，该公司累计全年销售额将达到428.8亿美元，这反映出该行业对创新生物科学技术和实验室产品在推动复杂生物学研究方面的持续依赖。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球细胞培养容器市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（可重复使用、一次性）
  • 依产品类型（袋子、保温瓶、盘子、瓶子、其他）
  • 透过申请（製药和生物技术公司、学术和研究机构、合约生产组织和合约研究组织）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美细胞培养容器市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲细胞培养容器市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区细胞培养容器市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲细胞培养容器市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美细胞培养容器市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球细胞培养容器市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific Inc.
• Merck KGaA
• STEMCELL Technologies Canada Inc.
• Greiner Bio-One International GmbH
• Corning Incorporated
• Wilson Wolf Manufacturing, LLC
• Danaher Corporation
• WR International, LLC.
• Sartorius AG
• Cell Culture Company, LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Cell Culture Vessels Market is projected to expand from USD 4.95 Billion in 2025 to USD 8.13 Billion by 2031, reflecting a CAGR of 8.62%. These vessels, which comprise specialized sterile containers such as multi-well plates, roller bottles, petri dishes, and flasks, are engineered to support cell maintenance and growth within controlled in vitro settings. The market's upward trajectory is primarily driven by the rapid growth of the biopharmaceutical sector, particularly the increasing demand for monoclonal antibodies, vaccines, and cell-based therapies needed to combat chronic diseases. Additionally, the intensification of drug discovery initiatives and stringent toxicity testing requirements ensures a consistent demand for these essential laboratory consumables.

Substantial financial commitment to scientific innovation further underpins this sector, directly fueling the usage of culture vessels. As reported by EFPIA, the research-based pharmaceutical industry in Europe allocated an estimated €55,000 million toward R&D in 2024. However, despite these favorable trends, the market confronts a significant obstacle regarding contamination control; the persistent threat of cross-contamination during culture processes poses a risk of expensive batch failures and compromised experimental data, representing a critical challenge for both manufacturers and researchers.

Market Driver

The escalating global demand for vaccines and biopharmaceuticals acts as a primary catalyst for the cell culture vessels market. As pharmaceutical developers focus on producing monoclonal antibodies and viral vectors, there is an intensified need for reliable, sterile containment systems like roller bottles and multi-well plates to facilitate large-scale upstream processing. This manufacturing momentum is highlighted by significant capital allocation toward infrastructure; for example, Novartis announced in an April 2025 corporate press release a plan to invest $23 billion over five years to broaden its U.S. manufacturing and R&D footprint. Such expansion translates into financial gains for consumable suppliers, with Corning Incorporated reporting in their January 2025 financial results that Life Sciences sales rose 8% to $2.0 billion for the year, largely due to sustained bioprocessing demand.

The rapid expansion of the stem cell and regenerative medicine industries further accelerates market growth by necessitating specialized cultivation environments. Unlike traditional biologics, cell and gene therapies often require advanced vessel geometries to ensure optimal gas exchange and cell adherence during the cultivation of autologous or allogeneic batches. This sector continues to attract significant funding, ensuring a steady procurement channel for high-performance culture apparatus. According to the Alliance for Regenerative Medicine's presentation at the 'Cell & Gene Meeting on the Mesa' in October 2024, global sector investments reached $10.9 billion in the first half of 2024 alone, funding clinical advancements that directly translate into increased volume requirements for critical single-use bags and flasks.

Market Challenge

Contamination control remains a formidable impediment to the Global Cell Culture Vessels Market, significantly constraining financial performance and operational efficiency. The inherent risk of cross-contamination during sensitive biopharmaceutical production forces manufacturers to implement extremely rigorous validation and sterilization measures. These necessary but burdensome protocols increase operational costs and extend production lead times, thereby reducing overall throughput. Furthermore, actual contamination events result in catastrophic batch failures, necessitating the disposal of high-value biologic products and causing severe delays in bringing critical therapies to market.

The industry's intense focus on mitigating these risks is quantitatively evident. According to the Parenteral Drug Association (PDA) in 2024, over 80% of surveyed manufacturers upgraded their validation protocols to meet tightening contamination control standards. This substantial allocation of resources toward sterility assurance and compliance diverts capital from innovation and capacity expansion. Consequently, the persistent threat of contamination not only jeopardizes product integrity but also creates high barriers to scalability and market entry, directly hampering the sector's growth trajectory.

Market Trends

The development of automation-compatible vessel designs is accelerating as biopharmaceutical manufacturers prioritize operational consistency and high-throughput screening. To integrate seamlessly with robotic plate movers and liquid handlers, vessel engineering is shifting toward standardized microplate footprints featuring rigid, gripper-friendly structures that eliminate the variability associated with manual manipulation. This industrial push for standardized, automation-ready consumables is reflected in the financial performance of major suppliers; for instance, Sartorius Stedim Biotech reported in its January 2025 preliminary results for fiscal 2024 that it generated sales revenue of €2,780 million, noting a distinct revitalization in its consumables business as customers normalized inventory levels to support automated bioprocessing activities.

Simultaneously, the emergence of specialized vessels for three-dimensional cell culture is transforming drug discovery workflows by providing environments that are more physiologically relevant than traditional monolayers. Researchers are increasingly procuring advanced scaffolds, microfluidic chips, and ultra-low attachment plates designed to facilitate the growth of organoids and spheroids, which offer superior predictive data for efficacy and toxicity testing. This demand for sophisticated culture platforms contributes significantly to the recurring revenue streams of life sciences leaders. As noted in Thermo Fisher Scientific's 'Fourth Quarter and Full Year 2024 Financial Results' released in January 2025, the company reported full-year revenue of $42.88 billion, reflecting the industry's sustained reliance on its innovative bioscience capabilities and laboratory products to advance complex biological research.

Key Market Players

• Thermo Fisher Scientific Inc.
• Merck KGaA
• STEMCELL Technologies Canada Inc.
• Greiner Bio-One International GmbH
• Corning Incorporated
• Wilson Wolf Manufacturing, LLC
• Danaher Corporation
• WR International, LLC.
• Sartorius AG
• Cell Culture Company, LLC

Report Scope

In this report, the Global Cell Culture Vessels Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Culture Vessels Market, By Type

• Reusable
• Single use

Cell Culture Vessels Market, By Product

• Bags
• Flasks
• Plates
• Bottles
• Others

Cell Culture Vessels Market, By End Use

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• CMOs & CROs

Cell Culture Vessels Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Culture Vessels Market.

Available Customizations:

Global Cell Culture Vessels Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Culture Vessels Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Reusable, Single use)
  • 5.2.2. By Product (Bags, Flasks, Plates, Bottles, Others)
  • 5.2.3. By End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CMOs & CROs)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Cell Culture Vessels Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Culture Vessels Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Cell Culture Vessels Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Cell Culture Vessels Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End Use

7. Europe Cell Culture Vessels Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell Culture Vessels Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Cell Culture Vessels Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Cell Culture Vessels Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Cell Culture Vessels Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Cell Culture Vessels Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End Use

8. Asia Pacific Cell Culture Vessels Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cell Culture Vessels Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Cell Culture Vessels Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Cell Culture Vessels Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Cell Culture Vessels Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Cell Culture Vessels Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Cell Culture Vessels Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cell Culture Vessels Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Cell Culture Vessels Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Cell Culture Vessels Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End Use

10. South America Cell Culture Vessels Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cell Culture Vessels Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Cell Culture Vessels Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Cell Culture Vessels Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cell Culture Vessels Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merck KGaA
• 15.3. STEMCELL Technologies Canada Inc.
• 15.4. Greiner Bio-One International GmbH
• 15.5. Corning Incorporated
• 15.6. Wilson Wolf Manufacturing, LLC
• 15.7. Danaher Corporation
• 15.8. WR International, LLC.
• 15.9. Sartorius AG
• 15.10. Cell Culture Company, LLC

16. Strategic Recommendations

17. About Us & Disclaimer